Drugstores are pulling Zantac-like heartburn drugs off the shelves over potential cancer risk

Off Health News

The U.S. Food and Drug Administration has been investigating the drugs’ possible risk to patients.

View original article
Contributor: Carolyn Y. Johnson

About The Author